LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure
Long-Term Oxygen Therapy (LTOT) in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure (CHF)
Sponsor: Azienda Ospedaliero-Universitaria Careggi
Listed as NCT00668408, this PHASE4 trial focuses on Chronic Heart Failure and Chronic Hypoxemia and remains ongoing. Sponsored by Azienda Ospedaliero-Universitaria Careggi, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
May 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliero-Universitaria Careggi
- University of Modena and Reggio Emilia
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Albano Laziale, Italy , Arezzo, Italy , Avellino, Italy , Bari, Italy , Barletta, Italy , Benevento, Italy , Bussolengo, Italy , Cagliari, Italy , Carrara, Italy , Castrovillari, Italy and 46 more locations